Sino Biological,Inc.

SZSE:301047 Stock Report

Market Cap: CN¥8.0b

Sino BiologicalInc Future Growth

Future criteria checks 3/6

Sino BiologicalInc is forecast to grow earnings and revenue by 24.9% and 15.6% per annum respectively. EPS is expected to grow by 25.5% per annum. Return on equity is forecast to be 3.9% in 3 years.

Key information

24.9%

Earnings growth rate

25.5%

EPS growth rate

Biotechs earnings growth43.4%
Revenue growth rate15.6%
Future return on equity3.9%
Analyst coverage

Low

Last updated19 Sep 2024

Recent future growth updates

Recent updates

Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 04
Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings

Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up

Sep 30
Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up

Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00

May 21
Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00

Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce

May 08
Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce

Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders

May 06
Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders

Earnings and Revenue Growth Forecasts

SZSE:301047 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026878264N/A2861
12/31/2025736208N/A2001
12/31/2024626162N/A1471
9/30/2024635154165221N/A
6/30/2024660195180233N/A
3/31/2024642220-562306N/A
12/31/2023646260-721323N/A
9/30/2023620232-826256N/A
6/30/2023568246-840263N/A
3/31/2023556272-112214N/A
1/1/202357530393249N/A
9/30/2022583440223357N/A
6/30/2022630470271368N/A
3/31/2022685502411470N/A
1/1/2022965720595643N/A
9/30/20211,3419339811,009N/A
6/30/20211,7361,2361,3171,338N/A
3/31/20211,9421,3961,2931,313N/A
12/31/20201,5961,1281,0751,093N/A
12/31/201918136842N/A
12/31/2018139361037N/A
12/31/201710113N/A23N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 301047's forecast earnings growth (24.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 301047's earnings (24.9% per year) are forecast to grow slower than the CN market (26.3% per year).

High Growth Earnings: 301047's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 301047's revenue (15.6% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 301047's revenue (15.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 301047's Return on Equity is forecast to be low in 3 years time (3.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y